ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Galecto Inc

Galecto Inc (GLTO)

4,96
0,03
(0,61%)
Geschlossen 01 Februar 10:00PM
4,96
0,00
(0,00%)
Nach Börsenschluss: 12:51AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
4,96
Gebot
4,83
Fragen
5,76
Volumen
8.099
4,90 Tagesbereich 5,35
4,4006 52-Wochen-Bereich 23,50
Marktkapitalisierung
Handelsende
4,93
Handelsbeginn
4,94
Letzte Trade
15
@
5.29
Letzter Handelszeitpunkt
Finanzvolumen
US$ 41.033
VWAP
5,0664
Durchschnittliches Volumen (3 Mio.)
18.823
Ausgegebene Aktien
1.316.989
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,17
Gewinn pro Aktie (EPS)
-29,12
Erlöse
-
Nettogewinn
-38,35M

Über Galecto Inc

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitor... Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Galecto Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GLTO. The last closing price for Galecto was US$4,93. Over the last year, Galecto shares have traded in a share price range of US$ 4,4006 to US$ 23,50.

Galecto currently has 1.316.989 shares in issue. The market capitalisation of Galecto is US$6,49 million. Galecto has a price to earnings ratio (PE ratio) of -0.17.

GLTO Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.53-9.653916211295.495.62344.7798265.21210828CS
4-0.79-13.73913043485.755.97994.6184215.37363356CS
12-2.14-30.14084507047.17.14.4006188235.46021688CS
26-8.915-64.252252252313.87515.134.400610454311.64601939CS
52-10.79-68.507936507915.7523.54.400614417214.88573406CS
156-52.29-91.336244541557.2592.54.400618020726.46086959CS
260-389.29-98.7419150285394.25449.754.400622190075.37221533CS

GLTO - Frequently Asked Questions (FAQ)

What is the current Galecto share price?
The current share price of Galecto is US$ 4,96
How many Galecto shares are in issue?
Galecto has 1.316.989 shares in issue
What is the market cap of Galecto?
The market capitalisation of Galecto is USD 6,49M
What is the 1 year trading range for Galecto share price?
Galecto has traded in the range of US$ 4,4006 to US$ 23,50 during the past year
What is the PE ratio of Galecto?
The price to earnings ratio of Galecto is -0,17
What is the reporting currency for Galecto?
Galecto reports financial results in USD
What is the latest annual profit for Galecto?
The latest annual profit of Galecto is USD -38,35M
What is the registered address of Galecto?
The registered address for Galecto is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Galecto website address?
The website address for Galecto is www.galecto.com
Which industry sector does Galecto operate in?
Galecto operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,71M
REBNReborn Coffee Inc
US$ 3,31
(63,05%)
55,54M
FCUVFocus Universal Inc
US$ 5,87
(56,62%)
1,73M
SOPASociety Pass Inc
US$ 1,54
(56,50%)
13,82M
CYCNCyclerion Therapeutics Inc
US$ 3,92
(54,33%)
82,39M
ENVBEnveric Biosciences Inc
US$ 2,0899
(-46,41%)
1,57M
NIVFNewGenIvf Group Ltd
US$ 0,1489
(-42,51%)
14,8M
GLSTGlobal Star Acquisition Inc
US$ 8,83
(-39,10%)
23,89k
PRPHProPhase Labs Inc
US$ 0,2633
(-38,02%)
872,26k
SPGCSacks Parente Golf Inc
US$ 0,5601
(-37,86%)
7,27M
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,71M
NVDANVIDIA Corporation
US$ 120,07
(-3,67%)
388,53M
RIMEAlgorhythm Holdings Inc
US$ 0,02565
(5,12%)
338,7M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0355
(-11,25%)
236,05M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1938
(30,77%)
234,74M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock